钆双酰胺（CAS 131410-48-5）：分子式 C16H26GdN5O8、分子量 573.66。
| CAS号 | 131410-48-5 |
|---|---|
| 分子式 | C16H26GdN5O8 |
| 分子量 | 573.66 |
| 应用领域 | Uses: Contrast Media、MEDICATION、For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions)、spine、and associated tissues、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >250、Use (kg) in USA (2002): 404、Consumption (g per capita、approx.) in Germany (2009): 0.00305、Consumption (g per capita) in the USA (2002): 0.00143、Methods of Manufacturing: Preparation: S. C. Quay、World Intellectual Property Organization (WIPO) patent 8602841 (1986 to New Salutar)、idem、United States of America patent 4687659 (1987 to Salutar).、Formulations、Preparations: Omniscan (gadodiamide) Injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide、and is an injectable、nonionic extracellular enhancing agent for magnetic resonance imaging. Omniscan is administered by intravenous injection. Omniscan is provided as a sterile、clear、colorless to slightly yellow、aqueous solution. Each 1 mL contains 287 mg gadodiamide and 12 mg caldiamide sodium in Water for Injection. |
登记用途：Uses: Contrast Media、MEDICATION、For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions)、spine、and associated tissues、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >250、Use (kg) in USA (2002): 404、Consumption (g per capita、approx.) in Germany (2009): 0.00305、Consumption (g per capita) in the USA (2002): 0.00143、Methods of Manufacturing: Preparation: S. C. Quay、World Intellectual Property Organization (WIPO) patent 8602841 (1986 to New Salutar)、idem、United States of America patent 4687659 (1987 to Salutar).、Formulations、Preparations: Omniscan (gadodiamide) Injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide、and is an injectable、nonionic extracellular enhancing agent for magnetic resonance imaging. Omniscan is administered by intravenous injection. Omniscan is provided as a sterile、clear、colorless to slightly yellow、aqueous solution. Each 1 mL contains 287 mg gadodiamide and 12 mg caldiamide sodium in Water for Injection.。
钆双酰胺 是一种化工化合物，登记 CAS 号为 131410-48-5，分子式 C16H26GdN5O8（分子量 573.66）。
登记 CAS 号：131410-48-5
其分子式 C16H26GdN5O8 由 16 个碳、26 个氢、1 个钆、5 个氮、8 个氧 组成。
别名/同义词：钆双酰胺 · Gadodiamide
钆双酰胺 的 CAS 登记号为 131410-48-5。
分子式 C16H26GdN5O8，分子量 573.66。
别名/同义词：钆双酰胺、Gadodiamide。
登记用途：Uses: Contrast Media、MEDICATION、For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions)、spine、and associated tissues、Typical contrast agents are gadolinium-based compounds that possess a higher linear attenuation coefficient than soft tissues.、Contrast agents、Use (kg、approx.) in Germany (2009): >250、Use (kg) in USA (2002): 404、Consumption (g per capita、approx.) in Germany (2009): 0.00305、Consumption (g per capita) in the USA (2002): 0.00143、Methods of Manufacturing: Preparation: S. C. Quay、World Intellectual Property Organization (WIPO) patent 8602841 (1986 to New Salutar)、idem、United States of America patent 4687659 (1987 to Salutar).、Formulations、Preparations: Omniscan (gadodiamide) Injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide、and is an injectable、nonionic extracellular enhancing agent for magnetic resonance imaging. Omniscan is administered by intravenous injection. Omniscan is provided as a sterile、clear、colorless to slightly yellow、aqueous solution. Each 1 mL contains 287 mg gadodiamide and 12 mg caldiamide sodium in Water for Injection.。
钆双酰胺（CAS 131410-48-5）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 131410-48-5 |
|---|---|
| PubChem CID | 153921 |
| Molecular formula | C16H26GdN5O8 |
| IUPAC name | 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+) |
| UNII (FDA) | 84F6U3J2R6 |
| Molecular Weight | 573.66 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 13 |
| Exact Mass | 574.10225 |
| Monoisotopic Mass | 574.10225 |
| Topological Polar Surface Area | 188 |
| Heavy Atom Count | 30 |
gadodiamide; 131410-48-5; GDDTPA-BMA; Gadodiamide anhydrous; Gadolinium-DTPA-BMA; Gd DTPA-BMA; S-041; 84F6U3J2R6; DTXSID201019701; HSDB 7547; DV 7572; CHEBI:37333; Gd-DTPA-BMA; RefChem:57217; Omniscan Unique Softpack; Gd-DTPA bis-(methylamide)
| Reported hazard statements | H319 (100%) |
|---|
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)
Gadodiamide · CAS 131410-48-5 · C16H26GdN5O8. UNII 84F6U3J2R6.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Gadodiamide